{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:57:34Z","timestamp":1756994254495},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1975,9,1]]},"DOI":"10.1172\/jci108128","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T14:26:30Z","timestamp":1204208790000},"page":"588-594","source":"Crossref","is-referenced-by-count":8,"title":["Human myeloma IgG half-molecules. Catabolism and biological properties."],"prefix":"10.1172","volume":"56","author":[{"given":"H L","family":"Spiegelberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/108128\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:54:46Z","timestamp":1691081686000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/108128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975,9,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1975,9,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci108128","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1975,9,1]]}}}